H. Liu Et Al. , "Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease," Metabolism: Clinical and Experimental , vol.126, 2022
Liu, H. Et Al. 2022. Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease. Metabolism: Clinical and Experimental , vol.126 .
Liu, H., Sridhar, V. S., Boulet, J., Dharia, A., Khan, A., Lawler, P. R., ... Cherney, D. Z.(2022). Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease. Metabolism: Clinical and Experimental , vol.126.
Liu, Hongyan Et Al. "Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease," Metabolism: Clinical and Experimental , vol.126, 2022
Liu, Hongyan Et Al. "Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease." Metabolism: Clinical and Experimental , vol.126, 2022
Liu, H. Et Al. (2022) . "Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease." Metabolism: Clinical and Experimental , vol.126.
@article{article, author={Hongyan Liu Et Al. }, title={Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease}, journal={Metabolism: Clinical and Experimental}, year=2022}